col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Scientific and Technological Research Council of Turkey: TURKISH JOURNAL OF MEDICAL SCIENCES
  original article Date Title Authors   All Authors
1 [GO] 2021―Nov―12 EVALUATION OF THE FREQUENCY and INTENSITY OF COVID-19 IN PATIENTS WITH ANKYLOSING SPONDYLITIS UNDER ANTI-TNF THERAPY
2 [GO] 2021―Nov―12 Effect of Tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospecitve cohort study
3 [GO] 2021―Nov―04 Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19
4 [GO] 2021―Oct―19 SARS-COV-2 vaccine: First-month results of a six-month follow-up study
5 [GO] 2021―Oct―06 Magnetic Resonance Imaging Findings in COVID-19-related Anosmia: Initial Results
6 [GO] 2021―Sep―30 Non-pharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic
7 [GO] 2021―Sep―30 COVID-19 and SEPSIS
8 [GO] 2021―Sep―19 Pregnancy and COVID-19: Prevention, Vaccination, Therapy and Beyond
9 [GO] 2021―Sep―08 A COVID-19 First Evaluation Clinic at a University Hospital in Turkey
10 [GO] 2021―Sep―08 Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves
11 [GO] 2021―Aug―29 Correlation of neuroimaging and thorax CT findings in patients with COVID-19: a large single-center experience
12 [GO] 2021―Aug―29 Clinical Characteristics and Risk Factors for 28-day Mortality in Critically Ill Patients with COVID-19: A Retrospective Cohort Study
13 [GO] 2021―Aug―27 From Asymptomatic to Critical Illness: Decoding Various Clinical Stages of COVID-19
14 [GO] 2021―Aug―21 Retrospective Evaluation of Seven Different Treatment Protocols in Hospitalized COVID-19 Patients
15 [GO] 2021―Aug―16 From asymptomatic to critical illness different clinical manifestations of COVID-19 in Children
16 [GO] 2021―Aug―16 Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients
17 [GO] 2021―Aug―15 Evaluating the efficiency of public policy measures against COVID-19
18 [GO] 2021―Aug―15 Antiviral treatment of COVID-19: An update
19 [GO] 2021―Aug―09 THE RADIOLOGICAL FINDINGS OF COVID-19
20 [GO] 2021―Aug―09 Short-Term Economic Impact of the Covid-19 Pandemic on the Global and Turkish Economy
21 [GO] 2021―Aug―09 Turkey?s Response to COVID-19 Pandemic: Strategy and Key Actions
22 [GO] 2021―Aug―09 RNA-Based COVID-19 Vaccine Candidates with Clinical Phase Trials in Progress
23 [GO] 2021―Aug―09 GLOBAL HEALTH EMERGENCIES DURING THE PANDEMIC AND THEIR SOLUTIONS
24 [GO] 2021―Aug―04 Comparison of SARS-COV2 antibody assays in PCR negative and PCR positive Turkish patients
25 [GO] 2021―Aug―02 Assessment of olfactory and gustatory functions in COVID-19 patients
26 [GO] 2021―Aug―02 Implementation of post-intensive care outpatient clinic (I-POINT) for critically-ill COVID-19 survivors
27 [GO] 2021―Aug―02 ALLERGIC REACTIONS AGAINST COVID-19 VACCINES
28 [GO] 2021―Jul―22 Current Infection Prevention and Control Strategies of COVID-19 in Hospitals
29 [GO] 2021―Jul―21 Managing life during the pandemic: Communication strategies, mental health and the ultimate toll of the COVID-19
30 [GO] 2021―Jul―21 One and a half years into the COVID-19 pandemic - Exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control
31 [GO] 2021―Jul―21 How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic
32 [GO] 2021―Jul―21 Pandemic Hospitals and Re-organizing Emergency Departments
33 [GO] 2021―Jul―07 Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity
34 [GO] 2021―Jun―27 Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
35 [GO] 2021―Jun―23 Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19
36 [GO] 2021―Jun―13 Effect of Coronavirus Pandemic on Organ Donation and Transplantation in Turkey
37 [GO] 2021―Jun―10 Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
38 [GO] 2021―Jun―07 COVID-19 third wave: A challenge for overburdened and shabby healthcare system of Pakistan
39 [GO] 2021―May―23 Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis
40 [GO] 2021―May―19 Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients?
41 [GO] 2021―May―07 Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study
42 [GO] 2021―May―07 Risk Factors Associated with Mortality in Intensive Care COVID-19 Patients: the importance of chest CT score and intubation timing as risk factors
43 [GO] 2021―Apr―30 First known COVID-19 case and contact tracing efforts in Istanbul, Turkey
44 [GO] 2021―Apr―23 Pleural complications of Covid-19 pneumonia
45 [GO] 2021―Apr―21 Pulse Steroid Treatment for Hospitalized Adults with COVID-19
46 [GO] 2021―Apr―21 The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
47 [GO] 2021―Apr―16 A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic
48 [GO] 2021―Apr―12 Impact of COVID-19 on serum melatonin levels and sleep parameters in children
49 [GO] 2021―Mar―28 Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis
50 [GO] 2021―Mar―17 Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
51 [GO] 2021―Mar―15 The Comparison of Lopinavir/Ritonavir Combination and Favipiravir In COVID-19 Treatment
52 [GO] 2021―Mar―11 Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic
53 [GO] 2021―Mar―08 The Relationship of Extent of Initial Radiological Involvement with the Need of Intensive Care, Mortality Rates and Laboratory Parameters in COVID-19.
54 [GO] 2021―Mar―08 CURRENT COMMUNITY TRANSMISSION AND FUTURE PERSPECTIVES ON THE COVID-19 PROCESS
55 [GO] 2021―Mar―01 An evaluation of chest computed tomography and hemogram data in patients with COVID-19: The importance of the thymus
56 [GO] 2021―Feb―22 Impact of Hospital-acquired Acute Kidney Injury on Covid-19 Outcomes in Patients with and without Chronic Kidney Disease: A multicentre, retrospective cohort study
57 [GO] 2021―Feb―22 Preferences of Inflammatory Arthritis Patients for Biological Disease-Modifying Antirheumatic Drugs in the First 100 Days of COVID-19 Pandemic
58 [GO] 2021―Feb―14 SARS-CoV-2 associated rhabdomyolysis in 32 patients
59 [GO] 2021―Feb―01 How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography
60 [GO] 2021―Jan―12 The clinical impact of the COVID-19 pandemic on daily urological practice: First 3 month multicenter results from Istanbul
61 [GO] 2021―Jan―10 Evaluation of Systemic Involvement of Coronavirus Disease 2019 through Spleen; Size and Texture Analysis
62 [GO] 2020―Dec―22 Consensus Recommendations for Botulinum Toxin Injections in the Spasticity Management of Children with Cerebral Palsy During COVID-19 Outbreak
63 [GO] 2020―Dec―14 Factors affecting mortality in geriatric patients hospitalized with COVID-19
64 [GO] 2020―Dec―14 Influence of aluminum salts on COVID-19 infected patients Ali DEMİR, İbrahim ERAYMAN, Oğuz DOĞAN, Murat KEKİLLİ
65 [GO] 2020―Dec―14 The predictive and diagnostic accuracy of long Pentraxin-3 in COVID-19 Pneumonia
66 [GO] 2020―Dec―14 Evaluation of Initial Chest CT Findings of COVID-19 Pneumonia in 117 Deceased Patients: a Retrospective Study
67 [GO] 2020―Dec―11 A SENSITIVE INDICATOR FOR THE SEVERITY OF COVID-19: THIOL
68 [GO] 2020―Nov―27 Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease and Implications for Clinical Trial Methodologies
69 [GO] 2020―Nov―25 Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey
70 [GO] 2020―Nov―16 THE IMPORTANCE OF QUALITY AND ACCREDITATION IN HEALTH CARE SERVICES IN THE PROCESS OF STRUGGLE AGAINST COVID-19
71 [GO] 2020―Nov―13 Clinical course of COVID-19 disease in immunosuppressed renal transplant patients
72 [GO] 2020―Nov―13 Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study
73 [GO] 2020―Oct―29 Pre-emptive Action Saves Lives in A Pandemic: Closing the Grand Bazaar Before The Fire Of COVID-19 Infection Starts
74 [GO] 2020―Oct―20 A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
75 [GO] 2020―Oct―06 Cerebral hemodynamic alterations in patients with Covid-19
76 [GO] 2020―Oct―06 COVID-19 transmission sources, management, and scientific research in Turkey
77 [GO] 2020―Oct―02 Do initial hematologic indices predict the severity of COVID-19 patients?
78 [GO] 2020―Sep―20 Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
79 [GO] 2020―Sep―20 Characteristics and Mortality Determinants of COVID-19 Patients Undergoing Haemodialysis
80 [GO] 2020―Aug―25 The impact of the "low molecular weight heparin" administration on the clinical course of COVID-19 disease
81 [GO] 2020―Aug―11 COVID-19 related anxiety in people living with HIV: An online cross-sectional study
82 [GO] 2020―Aug―11 Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly?
83 [GO] 2020―Jul―28 Perspectives for the immune plasma treatment of COVID-19
84 [GO] 2020―Jul―28 Hepatitis A susceptibility parallels high COVID-19 mortality
85 [GO] 2020―Jul―28 Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU
86 [GO] 2020―Jul―19 COVID-19 experience of the major pandemic response center in the capital: Results of the pandemic's first month in Turkey
87 [GO] 2020―Jul―19 The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data
88 [GO] 2020―Jun―30 COVID-19 and dermatology
89 [GO] 2020―Jun―30 The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey
90 [GO] 2020―Jun―12 Projecting the Course of COVID-19 in Turkey: A Probabilistic Modeling Approach
91 [GO] 2020―Jun―09 COVID-19: Pathogenesis, genetic polymorphism, flinical features and laboratory findings
92 [GO] 2020―Jun―04 The effects of blood group types on the risk of COVID-19 infection and its clinical outcome
93 [GO] 2020―May―31 Letter to the Editor: Radiological approaches to COVID-19 pneumonia
94 [GO] 2020―May―31 Response to letter to the editor: radiological approaches to COVID-19 pneumonia
95 [GO] 2020―May―31 Characteristics of the initial patients hospitalized for COVID-19: a single-center report
96 [GO] 2020―May―18 Is there relationship between SARS-CoV 2 and the complement C3 and C4?
97 [GO] 2020―May―12 Chest CT features of the novel coronavirus disease (COVID-19)
98 [GO] 2020―Apr―30 The usual course of thorax CT findings of Covid-19 infection and when should control thorax CT scan?
99 [GO] 2020―Apr―30 Gynecological laparoscopic surgery in the shade of COVID-19 pandemic
100 [GO] 2020―Apr―18 Novel coronavirus disease (COVID-19) in children Hasan TEZER, Tuğba BEDİR DEMİRDAĞ
101 [GO] 2020―Apr―18 COVID-19 outbreak control, example of ministry of health of Turkey Yasemin DEMİRBİLEK, Gülen PEHLİVANTÜRK, Zeynep Özge ÖZGÜLER, Emine ALP MEŞE
102 [GO] 2020―Apr―18 Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic Hasan MANDAL
103 [GO] 2020―Apr―18 Global surveillance, travel, and trade during a pandemic Ceren ÇETİN, Ateş KARA
104 [GO] 2020―Apr―17 Epidemiology of COVID-19 Cemal BULUT, Yasuyuki KATO
105 [GO] 2020―Apr―17 Protective measures for COVID-19 for healthcare providers and laboratory personnel Canan AĞALAR, Derya ÖZTÜRK ENGİN
106 [GO] 2020―Apr―17 COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs Abdurrahman TUFAN, Aslıhan AVANOĞLU GÜLER, Marco MATUCCI-CERINIC
107 [GO] 2020―Apr―17 Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic Zeliha KOÇAK TUFAN, Bircan KAYAASLAN
108 [GO] 2020―Apr―17 Radiological approaches to COVID-19 pneumonia Şule AKÇAY, Tevfik ÖZLÜ, Aydın YILMAZ
109 [GO] 2020―Apr―17 Understanding dynamics of pandemics Levent AKIN, Mustafa Gökhan GÖZEL
110 [GO] 2020―Apr―15 Antiviral treatment of COVID-19
111 [GO] 2020―Apr―15 Emerging and reemerging respiratory viral infections up to Covid-19
112 [GO] 2020―Apr―15 Critically-ill COVID-19 patient
113 [GO] 2020―Apr―15 COVID-19: Prevention and control measures in community
114 [GO] 2020―Apr―15 Coronaviruses and SARS-CoV-2
115 [GO] 2020―Apr―14 The early impact of the Covid-19 pandemic on the global and Turkish economy
116 [GO] 2020―Apr―14 SARS-CoV-2 epidemiology and control, different scenarios for Turkey


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec